Report and Accounts and Cash Position Update
30 Junio 2009 - 1:00AM
UK Regulatory
TIDMNWBS TIDMNWBT
RNS Number : 7202U
Northwest Biotherapeutics Inc
30 June 2009
For immediate release
June 30, 2009
Northwest Biotherapeutics
("NWBT" or the "Company")
Posting of Annual Report of Accounts and Update on Cash Position
Northwest Biotherapeutics, Inc. (AIM: NWBS and NWBT; OTC BB: NWBO.US),
announces that printed copies of its Annual Report and Accounts for the year
ended 31
December 2008 were distributed to shareholders on 29 June 2009. An electronic
copy of this document is available from the Company's website, and is also
available at the registered office of the Company.
The Company will hold its annual meeting later this summer.
The Company believes that it has sufficient cash at hand to fund operations into
July 2009, however the Company will need to raise additional capital to fund its
clinical trials and other operating activities and to repay indebtedness in due
course. Shareholders should be aware that if the Company's capital raising
efforts are unsuccessful, this will have a material adverse effect on the
Company's financial position and operations.
For further information, please contact:
Northwest Biotherapeutics
Alton Boynton, President and Chief Executive Officer
+1 240-497-9024
Buchanan Communications
Lisa Baderoon (lisab@buchanan.uk.com) / Mary-Jane Johnson /
Catherine Breen
+44 (0)20 7466 5000
Collins Stewart
Adam Cowen/Adrian Hadden +44 (0)20 7523 8000
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCPUUWGQUPBGQB
Northw.Bio Regs (LSE:NWBS)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Northw.Bio Regs (LSE:NWBS)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about Northw.Bio Regs (London Stock Exchange): 0 recent articles
Más de Northwest Bio. Artículos de Noticias